Inscopix launches nVista, a commercial grade miniature microscope-based brain imaging system for plug-and-play neural activity mapping at the Society for Neuroscience (SfN) Meeting.
Building the infrastructure
Inscopix builds its manufacturing facility at the Palo Alto headquarters and biological R&D labs in Mountain View for application development, training, and scientific research.
Inscopix starts building end-to-end solutions around the miniature microscope technology with the launch of Mosaic data analysis software.
A growing user base
Inscopix community grows to over 100 laboratories across the globe. These include 6 Nobelists and 23 HHMI investigators. First research article outside the founders lab is published in the top-tier journal Cell.
Series A, nVoke
Inscopix raises $10M in a Series financing round led by Playground Ventures. The company launches a second product, nVoke, for integrated brain activity imaging and manipulation at SFN Meeting.
The team grows to 60 FTEs and the user base expands to over 250 laboratories with over 425 systems in the field. The Inscopix community publishes 20 original research papers in top-tier journals.
Launching New Systems
Inscopix launches nVista 3.0 and nVoke 2.0 compatible with a new commutator. Currently over 50 peer-reviewed original research articles published using Inscopix technology, with 2 publications using nVoke. We also launched ready-to-image viruses!
Translational efforts begin
Launched two pharma collaborations with Biogen (in the area of chronic pain) and Astellas (in the area of psychiatric disorders). Successfully translated Inscopix platform into non-human primate models.
Inscopix is founded by Drs. Kunal Ghosh, Mark Schnitzer, and Abbas El Gamal to commercialize the Stanford miniature microscope invention. The company receives seed financing from Floodgate and Fidelity Biosciences.